Hauters P, Weerts J, Peillon C, Champault G, Bokobza B, Roeyen G, Totte E, Siriser F
Clinique Notre-Dame, 9 avenue Delmée, 7500 Tournai, Belgium.
Ann Chir. 2004 Jul-Aug;129(6-7):347-52. doi: 10.1016/j.anchir.2004.03.009.
To evaluate the clinical results of laparoscopic cystogastrostomy and to determine the potential advantages of this new therapeutic option.
This study concerned 12 patients presenting with pancreatic pseudocyst and operated on by laparoscopic cystogastrostomy between 1997 and 2002. There were five men and seven women with a median age of 46 years (range: 30-72). In ten patients, the pseudocyst developed after acute pancreatitis and the median delay between the acute onset and surgery was 7 months (range: 2-24). In two patients, the pseudocyst was associated with chronic pancreatitis. All the patients had a single cyst bulging into the posterior wall of the stomach and the median cyst diameter was 9 cm (range: 5-14).
Endoluminal gastric laparoscopy was used in six patients and intraperitoneal transgastric laparoscopy in six patients. Conversion to open surgery was required in one patient because the cyst could not be correctly localised by laparoscopy. The median size of the cystogastrostomy was 3 cm (range: 2-5). In eight patients, necrotic debris were still present within the cyst. The median operative time was 90 min (range: 60-140) and the median postoperative hospital stay was 6 days (range: 4-24). No mortality was recorded and postoperative morbidity was limited to one haematoma of the rectus sheath on a port site. One patient was readmitted on the 20th postoperative day because of cyst infection due to partial closure of the cystogastrostomy and was treated by endoscopic placement of a stent. One patient was lost for follow-up 2 months after surgery. With a median clinical and radiological follow-up of 12 months (range: 6-36), no recurrence of pancreatic pseudocyst was observed.
In this series, laparoscopic cystogastrostomy is associated with a low postoperative morbidity and an effective permanent result. Laparoscopy has two main advantages: an excellent control of haemostasis and the creation of a wide communication with debridement of the cyst contents thus minimizing the risk of infection or recurrence of the pseudocyst.
评估腹腔镜下囊肿胃造口术的临床效果,并确定这一新型治疗方法的潜在优势。
本研究涉及1997年至2002年间12例因胰腺假性囊肿接受腹腔镜囊肿胃造口术的患者。其中男性5例,女性7例,中位年龄46岁(范围:30 - 72岁)。10例患者的假性囊肿在急性胰腺炎后形成,急性发作至手术的中位间隔时间为7个月(范围:2 - 24个月)。2例患者的假性囊肿与慢性胰腺炎相关。所有患者均有单个囊肿向胃后壁突出,囊肿中位直径为9 cm(范围:5 - 14 cm)。
6例患者采用腔内胃腹腔镜检查,6例患者采用腹腔内经胃腹腔镜检查。1例患者因腹腔镜无法正确定位囊肿而转为开放手术。囊肿胃造口术的中位尺寸为3 cm(范围:2 - 5 cm)。8例患者的囊肿内仍有坏死碎片。中位手术时间为90分钟(范围:60 - 140分钟),中位术后住院时间为6天(范围:4 - 24天)。无死亡记录,术后并发症仅限于一个切口部位的腹直肌鞘血肿。1例患者在术后第20天因囊肿胃造口术部分闭合导致囊肿感染再次入院,接受内镜下支架置入治疗。1例患者术后2个月失访。临床及影像学中位随访时间为12个月(范围:6 - 36个月),未观察到胰腺假性囊肿复发。
在本系列研究中,腹腔镜囊肿胃造口术术后并发症发生率低,治疗效果持久有效。腹腔镜检查有两个主要优点:出色的止血控制以及通过清除囊肿内容物建立广泛的通道,从而将假性囊肿感染或复发的风险降至最低。